indirubin-3'-monoxime has been researched along with Angiogenesis, Pathologic in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JK | 1 |
| Shin, EK | 1 |
| Kang, YH | 1 |
| Park, JH | 1 |
1 other study available for indirubin-3'-monoxime and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Down-Regulation; Drugs, Chinese | 2011 |